Seroprevalence of RSV antibodies in a contemporary (2022-2023) cohort of adults
This study demonstrates a high seroprevalence of RSV-A IgG in adults, with variations across sex and seasonality, and corroborates waning immunity following RSV infection. Recent infection or vaccination significantly boosts antibody levels, reinforcing the importance of continued surveillance of RSV immunity.
Authors
- Inna G. Ovsyannikova (ORCID: https://orcid.org/0000-0003-1506-9214)
- Richard B. Kennedy
- Diane E. Grill (ORCID: https://orcid.org/0000-0002-8677-1724)
- Gregory A. Poland (ORCID: https://orcid.org/0000-0001-5057-4457)
- Lara I. Teodoro (ORCID: https://orcid.org/0000-0001-5383-3709)
Institutions
- Mayo Clinic (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- International Journal of Infectious Diseases
- Published
- 2025-06-21
- DOI
- https://doi.org/10.1016/j.ijid.2025.107964
- Citations
- 5
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 6.77
Funders
- Mayo Clinic